Form 8-K - Current report:
SEC Accession No. 0001193125-18-156763
Filing Date
2018-05-09
Accepted
2018-05-09 07:12:03
Documents
47
Period of Report
2018-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d551850d8k.htm 8-K 18090
2 EX-99.1 d551850dex991.htm EX-99.1 66102
3 EX-99.2 d551850dex992.htm EX-99.2 39094
4 GRAPHIC g551850ex99_2s10g1.jpg GRAPHIC 246120
5 GRAPHIC g551850ex99_2s11g1.jpg GRAPHIC 347724
6 GRAPHIC g551850ex99_2s12g1.jpg GRAPHIC 288202
7 GRAPHIC g551850ex99_2s13g1.jpg GRAPHIC 418793
8 GRAPHIC g551850ex99_2s14g1.jpg GRAPHIC 121195
9 GRAPHIC g551850ex99_2s15g1.jpg GRAPHIC 186365
10 GRAPHIC g551850ex99_2s16g1.jpg GRAPHIC 261063
11 GRAPHIC g551850ex99_2s17g1.jpg GRAPHIC 232041
12 GRAPHIC g551850ex99_2s18g1.jpg GRAPHIC 211940
13 GRAPHIC g551850ex99_2s19g1.jpg GRAPHIC 147303
14 GRAPHIC g551850ex99_2s1g1.jpg GRAPHIC 331926
15 GRAPHIC g551850ex99_2s20g1.jpg GRAPHIC 223601
16 GRAPHIC g551850ex99_2s21g1.jpg GRAPHIC 186632
17 GRAPHIC g551850ex99_2s22g1.jpg GRAPHIC 189838
18 GRAPHIC g551850ex99_2s23g1.jpg GRAPHIC 257048
19 GRAPHIC g551850ex99_2s24g1.jpg GRAPHIC 328858
20 GRAPHIC g551850ex99_2s25g1.jpg GRAPHIC 180345
21 GRAPHIC g551850ex99_2s26g1.jpg GRAPHIC 163111
22 GRAPHIC g551850ex99_2s27g1.jpg GRAPHIC 203695
23 GRAPHIC g551850ex99_2s28g1.jpg GRAPHIC 262645
24 GRAPHIC g551850ex99_2s29g1.jpg GRAPHIC 260237
25 GRAPHIC g551850ex99_2s2g1.jpg GRAPHIC 267799
26 GRAPHIC g551850ex99_2s30g1.jpg GRAPHIC 192964
27 GRAPHIC g551850ex99_2s31g1.jpg GRAPHIC 385754
28 GRAPHIC g551850ex99_2s32g1.jpg GRAPHIC 223323
29 GRAPHIC g551850ex99_2s33g1.jpg GRAPHIC 199137
30 GRAPHIC g551850ex99_2s34g1.jpg GRAPHIC 120348
31 GRAPHIC g551850ex99_2s35g1.jpg GRAPHIC 301989
32 GRAPHIC g551850ex99_2s36g1.jpg GRAPHIC 274707
33 GRAPHIC g551850ex99_2s37g1.jpg GRAPHIC 240748
34 GRAPHIC g551850ex99_2s38g1.jpg GRAPHIC 245350
35 GRAPHIC g551850ex99_2s39g1.jpg GRAPHIC 252625
36 GRAPHIC g551850ex99_2s3g1.jpg GRAPHIC 196038
37 GRAPHIC g551850ex99_2s40g1.jpg GRAPHIC 81508
38 GRAPHIC g551850ex99_2s41g1.jpg GRAPHIC 366654
39 GRAPHIC g551850ex99_2s42g1.jpg GRAPHIC 321547
40 GRAPHIC g551850ex99_2s43g1.jpg GRAPHIC 287605
41 GRAPHIC g551850ex99_2s4g1.jpg GRAPHIC 425558
42 GRAPHIC g551850ex99_2s5g1.jpg GRAPHIC 269104
43 GRAPHIC g551850ex99_2s6g1.jpg GRAPHIC 204848
44 GRAPHIC g551850ex99_2s7g1.jpg GRAPHIC 154405
45 GRAPHIC g551850ex99_2s8g1.jpg GRAPHIC 281510
46 GRAPHIC g551850ex99_2s9g1.jpg GRAPHIC 257038
47 GRAPHIC g551850img1.jpg GRAPHIC 24025
  Complete submission text file 0001193125-18-156763.txt   14761480
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37465 | Film No.: 18816653
SIC: 2834 Pharmaceutical Preparations